Cardif Colombia´ s profitability will strength in the next two years. We expect return on equity (ROE) of 18%-20%, given premiums growth of 18%-20%, because of improving economy and solid performance of commercial partners, contained commission rates and administrative costs, and better investment results. Strategic subsidiary of the parent. We continue viewing Cardif Colombia as a strategically important subsidiary of BNP Paribas S.A. (A+/Stable/A-1). Although the current rating on Cardif Colombia doesn't benefit from additional notches of group support, we consider that the group would have the ability and willingness to provide support to its Colombian subsidiary with capital injections and liquidity if needed. The stable outlook on Cardif Colombia reflects our expectation that the insurer will retain sufficient capital and liquidity